We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.58%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.28B
AUM Growth
–
Cap. Flow
+$4.21B
Cap. Flow
% of AUM
98.45%
Top 10 Holdings %
Top 10 Hldgs %
35.15%
Holding
665
New
665
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$172M |
| 2 |
Cardinal Health
CAH
|
+$170M |
| 3 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$152M |
| 4 |
Perrigo
PRGO
|
+$138M |
| 5 |
AGN
Allergan Inc
AGN
|
+$121M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.13% |
| 2 | Real Estate | 5.16% |
| 3 | Consumer Discretionary | 4.09% |
| 4 | Industrials | 3.09% |
| 5 | Consumer Staples | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Gilead Sciences
GILD
$166B
| $263M | 6.14% |
+5,120,600
| New | +$267M |
|
|
WCRX
2
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $179M | 4.18% |
+8,993,364
| New | +$152M |
|
|
ENDP
3
DELISTED
Endo International plc
ENDP
| $177M | 4.12% |
+4,797,676
| New | +$172M |
|
|
4
Cardinal Health
CAH
$54.5B
| $175M | 4.1% |
+3,717,935
| New | +$170M |
|
|
5
Perrigo
PRGO
$1.45B
| $140M | 3.28% |
+1,160,511
| New | +$138M |
|
6
Bausch Health
BHC
$1.68B
| $132M | 3.1% |
+1,539,019
| New | +$121M |
|
|
ESRX
7
DELISTED
Express Scripts Holding Company
ESRX
| $118M | 2.76% |
+1,913,833
| New | +$115M |
|
|
8
Gilead Sciences
GILD
$166B
| $116M | 2.72% |
+2,272,041
| New | +$118M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $105M | 2.45% |
+829,328
| New | +$93.9M |
|
|
AGN
10
DELISTED
Allergan Inc
AGN
| $98.6M | 2.3% |
+1,170,000
| New | +$121M |
|
|
MNTA
11
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $76.1M | 1.78% |
+5,050,000
| New | +$66.6M |
|
|
AVP
12
DELISTED
Avon Products, Inc.
AVP
| $71.7M | 1.68% |
+3,410,748
| New | +$76.6M |
|
13
Johnson & Johnson
JNJ
$645B
| $59.9M | 1.4% |
+697,674
| New | +$59.2M |
|
14
Pacira BioSciences
PCRX
$1.04B
| $58.3M | 1.36% |
+2,010,000
| New | +$58.1M |
|
15
Ventas
VTR
$47.5B
| $56.2M | 1.31% |
+708,719
| New | +$60.9M |
|
16
Healthpeak Properties
DOC
$15.6B
| $55.9M | 1.31% |
+1,350,273
| New | +$61.6M |
|
|
GRFS
17
Grifois
GRFS
$5.55B
| $54.7M | 1.28% |
+3,838,872
| New | +$53.9M |
|
18
Welltower
WELL
$173B
| $49.8M | 1.16% |
+742,374
| New | +$52.7M |
|
|
ELN
19
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| $49.3M | 1.15% |
+3,489,865
| New | +$43.2M |
|
20
Agilent Technologies
A
$39.5B
| $42.4M | 0.99% |
+1,384,792
| New | +$43M |
|
|
SNTS
21
DELISTED
SANTARUS INC
SNTS
| $42.1M | 0.98% |
+2,000,000
| New | +$40.2M |
|
|
WCG
22
DELISTED
Wellcare Health Plans, Inc.
WCG
| $40.9M | 0.96% |
+735,825
| New | +$41.1M |
|
|
ITMN
23
DELISTED
INTERMUNE INC
ITMN
| $37.1M | 0.87% |
+3,852,627
| New | +$36.8M |
|
24
Acadia Pharmaceuticals
ACAD
$4.45B
| $36.8M | 0.86% |
+2,027,787
| New | +$27.9M |
|
|
PCYC
25
DELISTED
PHARMACYCLICS INC
PCYC
| $34.6M | 0.81% |
+435,149
| New | +$35.6M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Visium Asset Management, which disclosed 665 positions worth $4.28B. Its ten largest holdings account for 35% of the portfolio.
Its largest position is Endo International plc: 4,797,676 shares worth $177M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Real Estate and Consumer Discretionary.
- Visium Asset Management's largest Q2 2013 buy was Endo International plc: 4,797,676 shares worth $177M.
- Visium Asset Management's ten largest holdings make up 35% of its $4.28B portfolio in Q2 2013.
- Visium Asset Management disclosed 665 positions in Q2 2013, its first 13F filing on record.
Based on Visium Asset Management's 13F filing for Q2 2013, filed 14 Aug 2013.